Company

Xenon Pharmaceuticals Inc.

Headquarters: Burnaby, BC, Canada

Employees: 149

CEO: Mr. Ian C. Mortimer C.M.A., CPA, CMA, CPA, M.B.A., MBA

NASDAQ: XENE +1.26%

Market Cap

$2.73 Billion

USD as of July 1, 2024

Market Cap History

Xenon Pharmaceuticals Inc. market capitalization over time

Evolution of Xenon Pharmaceuticals Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Xenon Pharmaceuticals Inc.

Detailed Description

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other potential indications, including adult focal epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop PCRX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Xenon Pharmaceuticals Inc. has the following listings and related stock indices.


Stock: NASDAQ: XENE wb_incandescent

Stock: FSX: XP0 wb_incandescent

Details

Headquarters:

200 – 3650 Gilmore Way

Burnaby, BC V5G 4W8

Canada

Phone: 604 484 3300

Fax: 604 484 3450